You are here
News
2025
Jul 2025 By the end of 2024, CBR had released over 750 cord blood units – 84% of them for use in regenerative medicine.
Jul 2025 As of the end of 2024, 620 families had used their cord blood stored with ViaCord for a stem cell transplant or regenerative medicine.
Jul 2025 By May of 2025, the FamiCord list of therapeutic applications included 7550 stem cell therapies. The majority, 69%, were peripheral blood and bone marrow processed by FamiCord laboratories for stem cell transplants. FamiCord released a total of 244 cord blood units for both stem cell transplants or regenerative medicine.
Jul 2025 The most important thing you need to know about pregnancy and labor is to keep your mindset "open and flexible". This is the first in a series of interviews with Labor and Delivery nurse Kim Petrella, who is an advisor to Parent’s Guide to Cord Blood Foundation.
Jul 2025 The 2025 AABB Annual Meeting will be held Oct. 25-28 in San Diego. This meeting brings together thousands of professionals in the fields of blood and biotherapies. Register by July 30 to save $300 on the full meeting registration.
Jun 2025 Recent evidence that therapies with cord blood and cord tissue have clear benefit for children with cerebral palsy have finally opened avenues of regenerative medicine that have long been promised by cord blood banks.
Jun 2025 Zara was the first child to receive a cord blood infusion to treat cerebral palsy under compassionate access regulations in Australia.
Jun 2025 Florida has passed a state law which “allows” stem cell therapies that are not approved by the FDA. The law initially allows licensed physicians to use adult stem cells to treat orthopedic issues, chronic pain, and wound healing.
Jun 2025 YES, pregnant mothers and their babies can still benefit from getting the COVID-19 vaccine in 2025, because the scientific evidence for getting vaccinated during pregnancy has not changed.
May 2025 The two companies Hemafund and Pluri have announced an exclusive collaboration to prepare for a radiation emergency in Ukraine. Pluri has a product made from live placenta cells that can protect against radiation poisoning, and Hemafund has a distribution network in Ukraine.